Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members, 33234-33235 [E7-11548]

Download as PDF 33234 Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices L. 104–13), the Health Resources and Services Administration (HRSA) will publish periodic summaries of proposed projects being developed for submission to OMB under the Paperwork Reduction Act of 1995. To request more information on the proposed project or to obtain a copy of the data collection plans, call the HRSA Reports Clearance Officer on (301) 443–1129. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques of other forms of information technology. Proposed Project: The Nursing Education Loan Repayment Program Application (OMB No. 0915–0140)— Revision This is a request for revision of the Nursing Education Loan Repayment Program (NELRP) application and participant monitoring forms. The NELRP was originally authorized by 42 U.S.C. 297b(h) (section 836(h) of the Public Health Service Act) as amended by Public Law 100–607, November 4, 1988. The NELRP is currently authorized by 42 U.S.C. 297n (section 846 of the Public Health Service Act) as amended by Public Law 107–205, August 1, 2002. Under the NELRP, registered nurses are offered the opportunity to enter into a contractual agreement with the Secretary to receive loan repayment for Responses per respondents Number of respondents Form Estimates of Annualized Hour Burden are as Follows for Applicants: NELRP Application ..................................................... Loan Verification Form ............................................... Applicant Employment Verification Form ................... Payment Information Form ......................................... Application Checklist ................................................... Pre-Award Confirmation Checklist .............................. up to 85 percent of their qualifying educational loan balance as follows: 30 percent each year for the first 2 years and 25 percent for the third year. In exchange, the nurses agree to serve fulltime as a registered nurse for 2 or 3 years at a health care facility with a critical shortage of nurses. NELRP requires the following information: 1. Applicants must provide information on their nursing education, employment, and proposed service site; 2. Applicants must provide information on their outstanding nursing educational loans; 3. Applicants must provide banking information from their financial institution; and 4. Employers must provide information on the health care facility and on the employment status of applicants and participants. Total responses Hours per response Total burden hours 5,000 5,000 5,000 5,000 5,000 600 1 3 1 1 1 1 5,000 15,000 5,000 5,000 5,000 600 1.5 1 .5 1 .5 .25 7,500 15,000 2,500 5,000 2,500 150 Total ..................................................................... Estimates of Annualized Hour Burden are as Follows for Participants: Participant Semi-Annual Employment Verification Form ........................................................................ 5,000 ........................ 35,600 .......................... 32,650 1,300 2 2,600 .5 1,300 Total ..................................................................... 1,300 2 2,600 .5 1,300 Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance Officer, Room 10–33 Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Written comments should be received with 60 days of this notice. Dated: June 11, 2007. Caroline Lewis, Associate Administrator for Management. [FR Doc. E7–11557 Filed 6–14–07; 8:45 am] jlentini on PROD1PC65 with NOTICES BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: SUMMARY: The Health Resources and Services Administration (HRSA) is requesting nominations to fill three vacancies on the Advisory Commission on Childhood Vaccines (ACCV). The ACCV was established by Title XXI of the Public Health Service Act (the Act), as enacted by Public Law (Pub. L.) 99– 660 and as subsequently amended, and advises the Secretary of Health and VerDate Aug<31>2005 19:26 Jun 14, 2007 Jkt 211001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Human Services (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). DATES: The agency must receive nominations on or before July 16, 2007. ADDRESSES: All nominations are to be submitted to the Director, Division of Vaccine Injury Compensation, Healthcare Systems Bureau (HSB), HRSA, Parklawn Building, Room 11C– 26, 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: Ms. Delia Jones, Principal Staff Liaison, Policy Analysis Branch, Division of Vaccine Injury Compensation, HSB, HRSA at (301) 443–6593 or e-mail: djones2@hrsa.gov. SUPPLEMENTARY INFORMATION: Under the authorities that established the ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92–463) and E:\FR\FM\15JNN1.SGM 15JNN1 jlentini on PROD1PC65 with NOTICES Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices section 2119 of the Act, 42 U.S.C. 300aa–19, as added by Public Law 99– 660 and amended, HRSA is requesting nominations for three voting members of the ACCV. The ACCV advises the Secretary on the implementation of the VICP. The activities of the ACCV include: recommending changes in the Vaccine Injury Table at its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying Federal, State, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b); advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; and recommending to the Director of the National Vaccine Program that vaccine safety research be conducted on various vaccine injuries. The ACCV consists of nine voting members appointed by the Secretary as follows: (1) Three health professionals, who are not employees of the United States Government and have expertise in the health care of children, and the epidemiology, etiology, and prevention of childhood diseases, and the adverse reactions associated with vaccines, at least two shall be pediatricians; (2) three members from the general public, at least two shall be legal representatives (parents or guardians) of children who have suffered a vaccine-related injury or death; and (3) three attorneys, at least one shall be an attorney whose specialty includes representation of persons who have suffered a vaccine-related injury or death, and one shall be an attorney whose specialty includes representation of vaccine manufacturers. In addition, the Director of the National Institutes of Health, the Assistant Secretary for Health, the Director of the Centers for Disease Control and Prevention, and the Commissioner of the Food and Drug Administration (or the designees of such officials) serve as nonvoting ex officio members. Specifically, HRSA is requesting nominations for three voting members of the ACCV representing: (1) A pediatrician who has expertise in the health care of children, the epidemiology, etiology, and prevention of childhood diseases, and the adverse reactions associated with vaccines; (2) a member of the general public who is the VerDate Aug<31>2005 19:26 Jun 14, 2007 Jkt 211001 legal representative of a child who has suffered a vaccine injury or death; and (3) an attorney whose specialty includes representation of persons who have suffered vaccine injuries or deaths. Nominees will be invited to serve a 3year term beginning January 1, 2008, and ending December 31, 2010. Interested persons may nominate one or more qualified persons for membership on the ACCV. Nominations shall state that the nominee is willing to serve as a member of the ACCV and appears to have no conflict of interest that would preclude the ACCV membership. Potential candidates will be asked to provide detailed information concerning consultancies, research grants, or contracts to permit evaluation of possible sources of conflicts of interest. A curriculum vitae or resume should be submitted with the nomination. The Department of Health and Human Services has special interest in assuring that women, minority groups, and the physically disabled are adequately represented on advisory committees; and therefore, extends particular encouragement to nominations for appropriately qualified female, minority, or disabled candidates. Dated: June 11, 2007. Caroline Lewis, Associate Administrator for Management. [FR Doc. E7–11548 Filed 6–14–07; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Meeting: Secretary’s Advisory Committee on Genetics, Health, and Society Pursuant to Public Law 92–463, notice is hereby given of the thirteenth meeting of the Secretary’s Advisory Committee on Genetics, Health, and Society (SACGHS), U.S. Public Health Service. The meeting will be held from on Tuesday, July 10, 2007, from 8:30 a.m. to approximately 5 p.m. in Room 800 of the Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20001. The meeting will be open to the public with attendance limited to space available. The meeting also will be Web cast. The meeting will focus primarily on the issue of gene patents and licensing practices and consist of a series of presentations and discussions involving international experts on how other countries are addressing questions related to the impact of gene patents and PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 33235 licensing practices on patient access to genetic tests. In addition, the SACGHS task force on oversight of genetic testing will present a brief report on the progress of its fact-finding and consultative efforts with regard to the Secretary’s charge. The Committee will also be updated about the public comments received in response to the Committee’s solicitation on its draft report on pharmacogenomics. Time will be provided for public comments. The Committee would welcome hearing from anyone wishing to provide public comment on any issue related to genetics, health, and society. Individuals who would like to provide public comment should notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at 301–496–9838 or e-mail at carrs@od.nih.gov. The SACGHS office is located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone planning to attend the meeting who is in need of special assistance, such as sign language interpretation or other reasonable accommodations, is also asked to contact the Executive Secretary. Under authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established SACGHS to serve as a public forum for deliberations on the broad range of human health and societal issues raised by the development and use of genetic and genomic technologies and, as warranted, to provide advice on these issues. The draft meeting agenda and other information about SACGHS, including information about access to the Web cast, will be available at the following Web site: http:// www4.od.nih.gov/oba/sacghs.htm. Dated: June 7, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2964 Filed 6–14–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine, Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the E:\FR\FM\15JNN1.SGM 15JNN1

Agencies

[Federal Register Volume 72, Number 115 (Friday, June 15, 2007)]
[Notices]
[Pages 33234-33235]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11548]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission of Childhood Vaccines; Request for 
Nominations for Voting Members

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
requesting nominations to fill three vacancies on the Advisory 
Commission on Childhood Vaccines (ACCV). The ACCV was established by 
Title XXI of the Public Health Service Act (the Act), as enacted by 
Public Law (Pub. L.) 99-660 and as subsequently amended, and advises 
the Secretary of Health and Human Services (the Secretary) on issues 
related to implementation of the National Vaccine Injury Compensation 
Program (VICP).

DATES: The agency must receive nominations on or before July 16, 2007.

ADDRESSES: All nominations are to be submitted to the Director, 
Division of Vaccine Injury Compensation, Healthcare Systems Bureau 
(HSB), HRSA, Parklawn Building, Room 11C-26, 5600 Fishers Lane, 
Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Ms. Delia Jones, Principal Staff 
Liaison, Policy Analysis Branch, Division of Vaccine Injury 
Compensation, HSB, HRSA at (301) 443-6593 or e-mail: djones2@hrsa.gov.

SUPPLEMENTARY INFORMATION: Under the authorities that established the 
ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 
92-463) and

[[Page 33235]]

section 2119 of the Act, 42 U.S.C. 300aa-19, as added by Public Law 99-
660 and amended, HRSA is requesting nominations for three voting 
members of the ACCV.
    The ACCV advises the Secretary on the implementation of the VICP. 
The activities of the ACCV include: recommending changes in the Vaccine 
Injury Table at its own initiative or as the result of the filing of a 
petition; advising the Secretary in implementing section 2127 regarding 
the need for childhood vaccination products that result in fewer or no 
significant adverse reactions; surveying Federal, State, and local 
programs and activities related to gathering information on injuries 
associated with the administration of childhood vaccines, including the 
adverse reaction reporting requirements of section 2125(b); advising 
the Secretary on the methods of obtaining, compiling, publishing, and 
using credible data related to the frequency and severity of adverse 
reactions associated with childhood vaccines; and recommending to the 
Director of the National Vaccine Program that vaccine safety research 
be conducted on various vaccine injuries.
    The ACCV consists of nine voting members appointed by the Secretary 
as follows: (1) Three health professionals, who are not employees of 
the United States Government and have expertise in the health care of 
children, and the epidemiology, etiology, and prevention of childhood 
diseases, and the adverse reactions associated with vaccines, at least 
two shall be pediatricians; (2) three members from the general public, 
at least two shall be legal representatives (parents or guardians) of 
children who have suffered a vaccine-related injury or death; and (3) 
three attorneys, at least one shall be an attorney whose specialty 
includes representation of persons who have suffered a vaccine-related 
injury or death, and one shall be an attorney whose specialty includes 
representation of vaccine manufacturers. In addition, the Director of 
the National Institutes of Health, the Assistant Secretary for Health, 
the Director of the Centers for Disease Control and Prevention, and the 
Commissioner of the Food and Drug Administration (or the designees of 
such officials) serve as nonvoting ex officio members.
    Specifically, HRSA is requesting nominations for three voting 
members of the ACCV representing: (1) A pediatrician who has expertise 
in the health care of children, the epidemiology, etiology, and 
prevention of childhood diseases, and the adverse reactions associated 
with vaccines; (2) a member of the general public who is the legal 
representative of a child who has suffered a vaccine injury or death; 
and (3) an attorney whose specialty includes representation of persons 
who have suffered vaccine injuries or deaths. Nominees will be invited 
to serve a 3-year term beginning January 1, 2008, and ending December 
31, 2010.
    Interested persons may nominate one or more qualified persons for 
membership on the ACCV. Nominations shall state that the nominee is 
willing to serve as a member of the ACCV and appears to have no 
conflict of interest that would preclude the ACCV membership. Potential 
candidates will be asked to provide detailed information concerning 
consultancies, research grants, or contracts to permit evaluation of 
possible sources of conflicts of interest. A curriculum vitae or resume 
should be submitted with the nomination.
    The Department of Health and Human Services has special interest in 
assuring that women, minority groups, and the physically disabled are 
adequately represented on advisory committees; and therefore, extends 
particular encouragement to nominations for appropriately qualified 
female, minority, or disabled candidates.

    Dated: June 11, 2007.
Caroline Lewis,
Associate Administrator for Management.
 [FR Doc. E7-11548 Filed 6-14-07; 8:45 am]
BILLING CODE 4165-15-P